Log in
Enquire now
‌

US Patent 11666259 Assessing developmental disorders via eye tracking

Patent 11666259 was granted and assigned to EarliTec Diagnostics on June, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
EarliTec Diagnostics
EarliTec Diagnostics
0
Date Filed
September 2, 2022
0
Date of Patent
June 6, 2023
0
Patent Applicant
EarliTec Diagnostics
EarliTec Diagnostics
0
Patent Application Number
17902415
0
Patent Citations
‌
US Patent 8434867 Finding sequential matches in eye tracking data
0
‌
US Patent 8668337 System for the physiological evaluation of brain function
0
‌
US Patent 9050035 Device to measure pupillary light reflex in infants and toddlers
0
‌
US Patent 9314157 Device to measure pupillary light reflex in infants and toddlers
0
‌
US Patent 9510752 Systems and methods for detecting blink inhibition as a marker of engagement and perceived stimulus salience
0
‌
US Patent 9629543 Internet-based cognitive diagnostics using visual paired comparison task
0
‌
US Patent 9854966 System and method for using microsaccade dynamics to measure attentional response to a stimulus
0
‌
US Patent 9861307 Systems and methods for detecting blink inhibition as a marker of engagement and perceived stimulus salience
0
‌
US Patent 9962119 System and method for detecting neurological disease
0
‌
US Patent 10010284 System for assessing a mental health disorder
0
•••
Patent Citations Received
‌
US Patent 11903711 Assessing developmental disorders via eye tracking
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11666259
0
Patent Primary Examiner
‌
Alex M Valvis
0

Find more entities like US Patent 11666259 Assessing developmental disorders via eye tracking

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.